Items where Funder is Tillotts Pharma AG.

Reference not given

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Alimentary Pharmacology & Therapeutics, 56 (1). pp. 110-120. ISSN 0269-2813

Cuffe, M.S., Goodoory, V.C., Ng, C.E. et al. (2 more authors) (2025) Epidemiology of Meal‐Related Abdominal Discomfort or Pain in Irritable Bowel Syndrome. Neurogastroenterology & Motility. e70174. ISSN 1350-1925

Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living. Alimentary Pharmacology and Therapeutics (AP&T), 56 (5). pp. 844-856. ISSN 0269-2813